Literature DB >> 31161210

eFORGE v2.0: updated analysis of cell type-specific signal in epigenomic data.

Charles E Breeze1,2, Alex P Reynolds2, Jenny van Dongen3, Ian Dunham4, John Lazar2, Shane Neph2, Jeff Vierstra2, Guillaume Bourque5, Andrew E Teschendorff6,7, John A Stamatoyannopoulos2, Stephan Beck1.   

Abstract

SUMMARY: The Illumina Infinium EPIC BeadChip is a new high-throughput array for DNA methylation analysis, extending the earlier 450k array by over 400 000 new sites. Previously, a method named eFORGE was developed to provide insights into cell type-specific and cell-composition effects for 450k data. Here, we present a significantly updated and improved version of eFORGE that can analyze both EPIC and 450k array data. New features include analysis of chromatin states, transcription factor motifs and DNase I footprints, providing tools for epigenome-wide association study interpretation and epigenome editing.
AVAILABILITY AND IMPLEMENTATION: eFORGE v2.0 is implemented as a web tool available from https://eforge.altiusinstitute.org and https://eforge-tf.altiusinstitute.org/. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2019. Published by Oxford University Press.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31161210      PMCID: PMC6853678          DOI: 10.1093/bioinformatics/btz456

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


1 Introduction

DNA methylation (DNAm) is the main epigenetic mark assayed in the study of human diseases. The new EPIC BeadChip developed by Illumina can detect DNAm at over 850 000 genomic sites, extending the promoter-centric coverage of the 450k array to enhancers identified by the ENCODE and FANTOM5 projects (Andersson ; ENCODE Project Consortium, 2012), constituting a powerful and robust new tool for epigenome-wide association studies (EWAS) (Moran ). The original version of eFORGE (Breeze ) employs multiple layers of epigenetic information, including data for open chromatin sites (DNase I hotspots) and histone marks (H3K4me1, H3K4me3, H3K27me3, H3K9me3 and H3K36me3) to detect cell types driving EWAS signal. The updated version of eFORGE extends and enhances the tool, adding new features, such as simultaneous analysis across 15 chromatin states, detection of transcription factor (TF) motifs associated with EWAS signal, cumulative DNase I footprint analysis, EPIC array support and a browser to analyze TF occupancy in EWAS loci. Notably, we incorporate many of these features into a new web-based suite, eFORGE-TF, to aid the multilevel characterization of TF-associated EWAS mechanisms.

2 Description

eFORGE v2.0 is a software tool written in Perl and Python. eFORGE takes a list of EWAS array probes, and tests them for overlap enrichment with epigenetic tracks using an extensive database of 815 individual datasets. eFORGE currently includes tracks for DNaseI hotspots, 5 histone marks and 15 chromatin states. Probes can be filtered using a 1-kb proximity filter, and can be input in either BED or probe ID format. Statistical enrichment analysis is performed using a binomial test against an array-specific background. eFORGE outputs key information including Benjamini–Yekutieli-corrected P-values, sample IDs and lists of probes overlapping tracks in each sample. Both static and interactive charts and tables are provided to view results (Fig. 1A).
Fig. 1.

Output examples of eFORGE v2.0. (A) Enrichment in brain enhancers and TSS flanking chromatin states for the top 200 sites from an Illumina EPIC array study (Moran ). (B) TF motifs with the highest enrichment for the top 1000 study probes, including two RFX5 motifs. (C) Distribution of study sites in aggregated RFX5 footprints from brain samples shows 6 of the 1000 top study probes overlapping 5 different positions within the motif (q-value =0.038, hypergeometric test, BY correction)

eFORGE chromatin state enrichment analysis extends previous eFORGE analyses by breaking down cell type-specific signal into regulatory element classes (e.g. subcategories of promoters, enhancers and transcribed regions). Furthermore, the activity of many of these classes is known to be associated with the binding of sequence-specific TFs. Interestingly, DNAm changes can also result as a consequence of the binding of sequence-specific TFs (Smith and Meissner, 2013). Output examples of eFORGE v2.0. (A) Enrichment in brain enhancers and TSS flanking chromatin states for the top 200 sites from an Illumina EPIC array study (Moran ). (B) TF motifs with the highest enrichment for the top 1000 study probes, including two RFX5 motifs. (C) Distribution of study sites in aggregated RFX5 footprints from brain samples shows 6 of the 1000 top study probes overlapping 5 different positions within the motif (q-value =0.038, hypergeometric test, BY correction) To break down cell type-specific signal into particular TF groups we have generated eFORGE-TF, a software suite that allows for TF analysis at three levels. First, it analyses the EWAS probe list for TF motif enrichment across all known TF motifs (Fig. 1B). This analysis can optionally be conditioned to DNase I footprints. Second, eFORGE-TF performs a cumulative analysis across an aggregated set of DNase I footprints to visualize DNAm changes in relation to particular basepairs of an aggregated footprint (Fig. 1C). Third, eFORGE-TF provides a locus-specific gallery to inspect individual probes using a combination of TF motifs and DNase I footprints. These three analysis levels provide a robust and comprehensive assessment of TF associations for a given EWAS probe list. In each gallery panel, eFORGE-TF includes an interactive browser for locus-specific analysis. This browser overlays multiple levels of information, such as footprints, TF motifs and genomic coordinates, providing an in-depth view into the TF associations of a particular locus. Such a tool can aid both EWAS interpretation and epigenome editing approaches, which can benefit from the characterization of local TF binding sites (Voigt and Reinberg, 2013). More details, including an example eFORGE analysis, are available (Supplementary Material).

3 Conclusion

This updated and improved version of eFORGE constitutes an extended and powerful tool for the analysis of Illumina EPIC and 450k array data. Click here for additional data file.
  6 in total

1.  Epigenome editing.

Authors:  Philipp Voigt; Danny Reinberg
Journal:  Nat Biotechnol       Date:  2013-12       Impact factor: 54.908

Review 2.  DNA methylation: roles in mammalian development.

Authors:  Zachary D Smith; Alexander Meissner
Journal:  Nat Rev Genet       Date:  2013-02-12       Impact factor: 53.242

3.  An atlas of active enhancers across human cell types and tissues.

Authors:  Robin Andersson; Claudia Gebhard; Michael Rehli; Albin Sandelin; Irene Miguel-Escalada; Ilka Hoof; Jette Bornholdt; Mette Boyd; Yun Chen; Xiaobei Zhao; Christian Schmidl; Takahiro Suzuki; Evgenia Ntini; Erik Arner; Eivind Valen; Kang Li; Lucia Schwarzfischer; Dagmar Glatz; Johanna Raithel; Berit Lilje; Nicolas Rapin; Frederik Otzen Bagger; Mette Jørgensen; Peter Refsing Andersen; Nicolas Bertin; Owen Rackham; A Maxwell Burroughs; J Kenneth Baillie; Yuri Ishizu; Yuri Shimizu; Erina Furuhata; Shiori Maeda; Yutaka Negishi; Christopher J Mungall; Terrence F Meehan; Timo Lassmann; Masayoshi Itoh; Hideya Kawaji; Naoto Kondo; Jun Kawai; Andreas Lennartsson; Carsten O Daub; Peter Heutink; David A Hume; Torben Heick Jensen; Harukazu Suzuki; Yoshihide Hayashizaki; Ferenc Müller; Alistair R R Forrest; Piero Carninci
Journal:  Nature       Date:  2014-03-27       Impact factor: 49.962

4.  eFORGE: A Tool for Identifying Cell Type-Specific Signal in Epigenomic Data.

Authors:  Charles E Breeze; Dirk S Paul; Jenny van Dongen; Lee M Butcher; John C Ambrose; James E Barrett; Robert Lowe; Vardhman K Rakyan; Valentina Iotchkova; Mattia Frontini; Kate Downes; Willem H Ouwehand; Jonathan Laperle; Pierre-Étienne Jacques; Guillaume Bourque; Anke K Bergmann; Reiner Siebert; Edo Vellenga; Sadia Saeed; Filomena Matarese; Joost H A Martens; Hendrik G Stunnenberg; Andrew E Teschendorff; Javier Herrero; Ewan Birney; Ian Dunham; Stephan Beck
Journal:  Cell Rep       Date:  2016-11-15       Impact factor: 9.423

5.  An integrated encyclopedia of DNA elements in the human genome.

Authors: 
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

6.  Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences.

Authors:  Sebastian Moran; Carles Arribas; Manel Esteller
Journal:  Epigenomics       Date:  2015-12-17       Impact factor: 4.778

  6 in total
  29 in total

1.  Cell Type-Specific Signal Analysis in Epigenome-Wide Association Studies.

Authors:  Charles E Breeze
Journal:  Methods Mol Biol       Date:  2022

2.  Epigenome-wide association study of mitochondrial genome copy number.

Authors:  Penglong Wang; Christina A Castellani; Jie Yao; Tianxiao Huan; Lawrence F Bielak; Wei Zhao; Jeffrey Haessler; Roby Joehanes; Xianbang Sun; Xiuqing Guo; Ryan J Longchamps; JoAnn E Manson; Megan L Grove; Jan Bressler; Kent D Taylor; Tuuli Lappalainen; Silva Kasela; David J Van Den Berg; Lifang Hou; Alexander Reiner; Yongmei Liu; Eric Boerwinkle; Jennifer A Smith; Patricia A Peyser; Myriam Fornage; Stephen S Rich; Jerome I Rotter; Charles Kooperberg; Dan E Arking; Daniel Levy; Chunyu Liu
Journal:  Hum Mol Genet       Date:  2021-12-27       Impact factor: 5.121

3.  Maternal Dietary Glycemic Index and Glycemic Load in Pregnancy and Offspring Cord Blood DNA Methylation.

Authors:  Leanne K Küpers; Sílvia Fernández-Barrés; Giulia Mancano; Laura Johnson; Raffael Ott; Jesus Vioque; Marco Colombo; Kathrin Landgraf; Elmar W Tobi; Antje Körner; Romy Gaillard; Jeanne H M de Vries; Vincent W V Jaddoe; Martine Vrijheid; Gemma C Sharp; Janine F Felix
Journal:  Diabetes Care       Date:  2022-08-01       Impact factor: 17.152

4.  Longitudinal Study of DNA Methylation and Epigenetic Clocks Prior to and Following Test-Confirmed COVID-19 and mRNA Vaccination.

Authors:  Alina P S Pang; Albert T Higgins-Chen; Florence Comite; Ioana Raica; Christopher Arboleda; Hannah Went; Tavis Mendez; Michael Schotsaert; Varun Dwaraka; Ryan Smith; Morgan E Levine; Lishomwa C Ndhlovu; Michael J Corley
Journal:  Front Genet       Date:  2022-06-03       Impact factor: 4.772

5.  Maternal Mediterranean diet in pregnancy and newborn DNA methylation: a meta-analysis in the PACE Consortium.

Authors:  Leanne K Küpers; Sílvia Fernández-Barrés; Aayah Nounu; Chloe Friedman; Ruby Fore; Giulia Mancano; Dana Dabelea; Sheryl L Rifas-Shiman; Rosa H Mulder; Emily Oken; Laura Johnson; Mariona Bustamante; Vincent W V Jaddoe; Marie-France Hivert; Anne P Starling; Jeanne H M de Vries; Gemma C Sharp; Martine Vrijheid; Janine F Felix
Journal:  Epigenetics       Date:  2022-03-02       Impact factor: 4.861

6.  DNA Methylation Analysis to Unravel Altered Genetic Pathways Underlying Early Onset and Late Onset Neonatal Sepsis. A Pilot Study.

Authors:  Sheila Lorente-Pozo; Paula Navarrete; María José Garzón; Inmaculada Lara-Cantón; Jesús Beltrán-García; Rebeca Osca-Verdegal; Salvador Mena-Mollá; Eva García-López; Máximo Vento; Federico V Pallardó; José Luis García-Giménez
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

7.  Genetic and in utero environmental contributions to DNA methylation variation in placenta.

Authors:  Suvo Chatterjee; Marion Ouidir; Fasil Tekola-Ayele
Journal:  Hum Mol Genet       Date:  2021-10-13       Impact factor: 5.121

8.  Methylome-wide association study of antidepressant use in Generation Scotland and the Netherlands Twin Register implicates the innate immune system.

Authors:  Miruna C Barbu; Floris Huider; Archie Campbell; Carmen Amador; Mark J Adams; Mary-Ellen Lynall; David M Howard; Rosie M Walker; Stewart W Morris; Jenny Van Dongen; David J Porteous; Kathryn L Evans; Edward Bullmore; Gonneke Willemsen; Dorret I Boomsma; Heather C Whalley; Andrew M McIntosh
Journal:  Mol Psychiatry       Date:  2021-12-08       Impact factor: 13.437

9.  Cord blood DNA methylation reflects cord blood C-reactive protein levels but not maternal levels: a longitudinal study and meta-analysis.

Authors:  Edwina H Yeung; Weihua Guan; Xuehuo Zeng; Lucas A Salas; Sunni L Mumford; Paula de Prado Bert; Evelien R van Meel; Anni Malmberg; Jordi Sunyer; Liesbeth Duijts; Janine F Felix; Darina Czamara; Esa Hämäläinen; Elisabeth B Binder; Katri Räikkönen; Jari Lahti; Stephanie J London; Robert M Silver; Enrique F Schisterman
Journal:  Clin Epigenetics       Date:  2020-04-30       Impact factor: 6.551

10.  DNA Methylome Alterations Are Associated with Airway Macrophage Differentiation and Phenotype during Lung Fibrosis.

Authors:  Peter McErlean; Christopher G Bell; Richard J Hewitt; Zabreen Busharat; Patricia P Ogger; Poonam Ghai; Gesa J Albers; Emily Calamita; Shaun Kingston; Philip L Molyneaux; Stephan Beck; Clare M Lloyd; Toby M Maher; Adam J Byrne
Journal:  Am J Respir Crit Care Med       Date:  2021-10-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.